Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Local tranexamic acid to reduce postoperative bleeding in coronary artery bypass graft surgery
IRCT20141209020258N62Phase 3Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tranexamic acid in coronary arteriosclerosis, sponsored by Arak University of Medical Sciences. Primary endpoint: Postoperative bleeding volume. Started Nov 2017; status: completed.
02
Drugs
tranexamic acid
03
Conditions
coronary arteriosclerosis
Beyond the preview
Go deeper on IRCT20141209020258N62.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141209020258N62.